FDA calls for investigation of Biogen Alzheimer's drug approval

Triangle Business Journal

Jul 10, 2021

Following weeks of pushback, the head of the FDA has called for an investigation into the approval of Aduhelm, the Alzheimer's disease drug made by Biogen and produced in RTP.